Skip to main content
Caplight Logo









HelixNano

HelixNano

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.helixnano.com/

Last Round

Grant

Sep 18, 2024

Total Funding Raised

$2.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

HelixNano is a biotechnology company that develops advanced mRNA platforms, vaccines, and therapies to augment the immune system's ability to fight diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

mRNA therapeuticsmRNA vaccinedrug discoverysynthetic DNAbiotechAI drug discoveryprecision medicinein silico drug designcomputational biologymRNA platformimmunotherapygenomicsAI biotechclinical trialsthermostable vaccines

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HelixNano Comparables

Compare HelixNano with similar companies based on industry and business-model similarity.

HelixNano comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RNAimmune
84%
Replicate Bioscience
83%
Kernalbio
80%

HelixNano Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 18, 2024
VC RoundApr 29, 2024
GrantMar 1, 2021
GrantFeb 8, 2019
AcceleratorAug 22, 2017

Key People

Founding team and executive leadership

Hannu Rajaniemi

Co-Founder And CEO

Founding Team

HelixNano Investors

Notable investors and investment history

HelixNano investors
InvestorRounds
Milano Investment PartnersAccelerator
Thiel CapitalVC Round, Accelerator
Founders FundVC Round, Accelerator
Yes VCAccelerator
LongeVCVC Round
Schmidt FuturesGrant
Bill & Melinda Gates FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 34% MoM.

  • Aug 4, 2025

    Exploring development of thermostable infectious disease vaccines.

HelixNano Filings

Explore SEC and related filing metadata, where available.

HelixNano filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about HelixNano's valuation, stock price, and market status.

Is HelixNano a public or private company?

HelixNano is a private company.

What is the current stock price of HelixNano?

HelixNano is a private company with no public stock price. No recent secondary market data is available.

How much is HelixNano worth (valuation)?

Valuation information for HelixNano is not publicly available.

Can I buy HelixNano stock?

HelixNano shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was HelixNano's last funding round?

HelixNano's most recent funding round was VC Round on April 29, 2024.

Who are the main investors in HelixNano?

Key investors in HelixNano include Milano Investment Partners, Thiel Capital, Founders Fund, Yes VC, LongeVC.

Will HelixNano IPO soon?

No public IPO plans have been announced for HelixNano.

How can I track HelixNano secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HelixNano's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range12
Year Founded2013
Last FundingSep 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?